Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

CLL, Image credit:   LASZLO– stock.adobe.com
Lisaftoclax NDA Accepted for Review in China for Relapsed/Refractory CLL/SLL

November 20th 2024

An NDA for lisaftoclax in relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma has been accepted for review.

FDA
FDA Approves New Drug Labeling for Fludarabine Phosphate in CLL

November 20th 2024

Chronic Lymphocytic Leukemia
Piecing Together the Proper BTK Usage in CLL

November 13th 2024

First-Line Zanubrutinib in CLL/SLL
First-Line Zanubrutinib Prolongs PFS in Real-World Study of Chinese Patients With CLL/SLL

November 13th 2024

OncLive's Top 5 Stories of the Week in Oncology
The OncFive: Top Oncology Articles for the Week of 11/3

November 9th 2024

Latest CME Events & Activities